ML-OVA was shown to inhibit HIV-1 Env-mediated cell-cell fusion (Table 2), suggesting that it may inhibit HIV-1 infection by blocking HIV-1 entry. The gene discussed is ERVW-1; the disease is HIV-1 infection.